• 2011

Company Description

Endonovo Therapeutics is a biotechnology company developing off-the-shelf regenerative products.

Endonovo Therapeutics, Inc. (OTCQB: ENDV) is a biotechnology company developing off-the-shelf regenerative products that no longer require the injection of stem cells. Our first platform, Cell Free Therapeutics, harnesses the biological secretions of cells to create therapies that can be immediately administered following injuries or to treat acute and chronic diseases. Our second platform is the development of non-invasive, bioelectronics to stimulate the body's natural repair system to treat injuries and inflammatory diseases.